Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GI Dynamics teams up with Medtronic, GSK for EndoBarrier research
FierceMedicalDevice
Friday, January 4, 2013 - 11:48am
tags:
GI Dynamics, Medtronic, GSK, EndoBarrier, research
Immucor to Acquire the LIFECODES(R) Business From Hologic, Inc.
Yahoo/GlobeNewswire
Friday, January 4, 2013 - 11:43am
tags:
Immucor, LIFECODES, Hologic, M&A
Biogen Idec Submits Application to FDA for First Long-Lasting Factor IX Therapy for Hemophilia B
Yahoo
Friday, January 4, 2013 - 11:43am
tags:
FDA, hemophilia B, Biogen Idec, rFIXFc
Upcoming Catalysts For Vivus
Seeking Alpha
Friday, January 4, 2013 - 11:41am
tags:
Vivus, Qsymia
What Sunshine Rules? CMS Fails To Deliver, Again
Pharmalot
Friday, January 4, 2013 - 11:40am
tags:
Physician Payment Sunshine Act, CMS
2 Impending Biotech Catalysts To Start Off 2013
Seeking Alpha
Friday, January 4, 2013 - 11:36am
tags:
NuPathe, Impax, Rytary, Parkinson's Disease, Zecurity, migraines
InterMune says 4Q lung disease drug sales improved
Yahoo/AP
Friday, January 4, 2013 - 11:34am
tags:
earnings, InterMune
Amicus Theraputics announces positive results from Phase 2 Chaperone-ERT study
The Fly on the Wall
Friday, January 4, 2013 - 11:32am
tags:
Amicus Therapeutics, AT2220, Pompe disease
AngioDynamics Reports Fiscal 2013 Second Quarter Financial Results
Yahoo/GlobeNewswire
Friday, January 4, 2013 - 11:30am
tags:
AngioDynamics, earnings
Insulet Corporation Announces the Sale of $85 Million of Common Stock
Yahoo/MarketWire
Friday, January 4, 2013 - 11:30am
tags:
Insulet, stock
Discovery Labs Announces Changes to Board of Directors and Appoints a New Chief Executive Officer
CP Wire
Friday, January 4, 2013 - 11:29am
tags:
Discovery Labs
Discovery Labs Initiates Launch of AFECTAIR®
CP Wire
Friday, January 4, 2013 - 11:29am
tags:
Discovery Labs, Afectair
Lilly Forecasts Full-Year Profit Higher Than Estimates
Bloomberg
Friday, January 4, 2013 - 11:23am
tags:
Eli Lilly, earnings
3 Biotech Stocks You Can Buy in 2013
Motley Fool
Friday, January 4, 2013 - 11:16am
tags:
Gilead, Exelixis, Dendreon
The Many Reasons to Still Own Abbott Labs
TheStreet.com
Friday, January 4, 2013 - 11:15am
tags:
Abbott Labs
Analysis: Alimta patent seen as Lilly's "wild card"
Yahoo/Reuters
Friday, January 4, 2013 - 10:05am
tags:
Alimta, Eli Lilly, lung cancer
Abbott, J&J, Sanofi Said to Show Bausch & Lomb Interest
Bloomberg
Friday, January 4, 2013 - 9:53am
tags:
Abbott Labs, JNJ, Sanofi, Bausch & Lomb, M&A
AbbVie Plans Specialty Drug Focus in Sales Growth Effort
Bloomberg
Friday, January 4, 2013 - 9:52am
tags:
AbbVie, endometriosis, Parkinson's Disease
Color Matters: Pills And Patient Adherence
Pharmalot
Thursday, January 3, 2013 - 3:55pm
tags:
drugs, research, study
Bayer closes deal for Teva US animal health unit
Yahoo/AP
Thursday, January 3, 2013 - 3:54pm
tags:
Teva, Bayer, animal

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.